Every round on record, with the sources behind each and the investors on them.
Immunomatics, Inc. sells AI-based tools designed to enhance transplant donor-recipient risk assessment, primarily for healthcare providers in transplantation.
immunomatics.comHealthtechFounded 2024
3 sources · checked 1 time, last 2h ago
The release describes this as a strategic investment rather than a named financing round; no round stage, valuation, or larger financing total is stated.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $100K | 2026-10-07 | not stated | 3 outlets. #65 in Trending |
3 sources · checked 1 time, last 2h ago [ VERIFIED ] read against 1 of 3 sources The release describes this as a strategic investment rather than a named financing round; no round stage, valuation, or larger financing total is stated. | ||||
Also named as backers in company research: National Institutes of Health (NIH), NIH SBIR, Myosotis Investments B.V., Keith Robison, PhD, Georgia Nicholls